Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

The Science Behind Kensington Capital Could Electrify Your Portfolio

By Josh Enomoto, InvestorPlace Contributor

Solid-state batteries (SSBs) represent the future of electric vehicles, bolstering the narrative for KCAC stock. However, investors should know what makes SSBs distinct -- and the challenges that lie ahead.

9 Video Game Stocks to Buy for Next-Gen Gains

By Josh Enomoto, InvestorPlace Contributor

Video games offered a respite from the shock of the novel coronavirus. So, logically, lightning could strike twice for this viable sector.

Windows of Opportunity Are Tightening for Sorrento Therapeutics

By Josh Enomoto, InvestorPlace Contributor

Thanks to Sorrento Therapeutics’ all-out pivot to address the Covid-19 pandemic, SRNE stock initially became one of the most popular investments. But as both the vaccine and treatment race tighten, the risks multiply.

Slack Just Got a Lifeline from Salesforce Buyout Talks

By Josh Enomoto, InvestorPlace Contributor

Finally, investors were justified in holding onto WORK stock. However, it's still a question what the proposed deal will mean for CRM stock?

Hyliion Stock Could Be Science’s Version of Affidavits

By Josh Enomoto, InvestorPlace Contributor

Hyliion stock seems like a compelling idea on paper, but it’s in the finer details where the narrative gets incredibly complicated.

Load More